Results for this period
Interim period (second quarter)1 September 2025–28 February 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The factors included the reaction to the strong 6.1% increase in the same period of the previous year, progress on renewal projects and the carryover of large-scale projects in the core market, lower revenue from patient wear in surrounding markets, the Taiwan projects in overseas markets and the effect of opening the Seoul branch, and higher raw material prices, domestic factory processing fees and personnel expenses.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 September 2025–28 February 2026 |
| Net Sales | ¥7,861 million (YoY +0.2%) |
| Operating profit | ¥1,381 million (YoY -7.9%) |
| Ordinary income | ¥1,475 million (YoY -4.4%) |
| Profit attributable to owners of the parent | ¥1,014 million (YoY -4.5%) |
| Net income per share | ¥33.53 |
| Equity ratio | End of the current fiscal period 92.5 / End of previous period 92.5 |
| Total assets | ¥41,467 million |
| Net assets | ¥38,369 million |
| Cash flows from operating activities | ¥-425,106 thousand |
| Cash flows from investing activities | ¥3,741,366 thousand |
| Cash flows from financing activities | ¥-4,047,695 thousand |
| Cash and cash equivalents at end of period | ¥4,017,231 thousand |
| Full-year earnings forecast | Net Sales ¥18,000 million (YoY +6.0%) / Operating profit ¥4,025 million (YoY +12.3%) / Ordinary income ¥4,200 million (YoY +13.3%) / Net income ¥2,900 million (YoY +12.7%) |
| Annual Dividend Forecast | ¥100 → ¥60（-40.0%） |
| Depreciation and amortization | ¥142,113 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥672 thousand / Extraordinary loss Loss on disposal and sale of non-current assets ¥96 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for securities analysts) |
| Issued Shares at Period-End | 30,736,000 Shares |
| Treasury Shares at Period-End | 766,526 Shares |
| Factors Behind Changes in Business Performance | The factors included the reaction to the strong 6.1% increase in the same period of the previous year, progress on renewal projects and the carryover of large-scale projects in the core market, lower revenue from patient wear in surrounding markets, the Taiwan projects in overseas markets and the effect of opening the Seoul branch, and higher raw material prices, domestic factory processing fees and personnel expenses. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to the continued impact of higher raw material prices and rising processing fees at domestic factories, selling, general and administrative expenses increased 6.1% year on year due to higher personnel expenses associated with wage increases and other factors.